Drug intelligence / Profile preview

salacinol

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intraperitoneal, Intestinal
01

Overview

Salacinol is a naturally occurring sulfonium-ion thiosugar compound isolated from the roots and stems of Salacia species (notably Salacia reticulata and Salacia oblonga), plants used in traditional medicine. It is a potent inhibitor of intestinal alpha-glucosidases—enzymes responsible for breaking down complex carbohydrates into glucose in the gut. By inhibiting these enzymes (including maltase and sucrase), salacinol delays carbohydrate digestion and absorption after meals (postprandial), resulting in reduced blood glucose spikes. Its mechanism is similar to that of acarbose but with higher potency in some studies. The primary therapeutic interest for salacinol lies in managing type 2 diabetes by controlling postprandial hyperglycemia; it has also been explored as a lead compound for new antidiabetic drugs and functional foods targeting metabolic disorders[7][9][10].

Other names
neosalacinol[(2S,3S)-4-[(2R,3S,4S)-3,4-dihydroxy-2-(hydroxymethyl)thiolan-1-ium-1-yl]-1,3-dihydroxybutan-2-yl] sulfate((2S,3S)-4-((2R,3S,4S)-3,4-dihydroxy-2-(hydroxymethyl)thiolan-1‑ium‑1‑yl)-1,3-dihydroxybutan‑2‑yl) sulfate
02

Targets

Sucrase-Isomaltase

Beyond the preview

Go deeper on salacinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salacinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call